SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.
about
The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium.Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia.JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.Momelotinib therapy for myelofibrosis: a 7-year follow-up.Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors
P2860
Q47581193-1844BA89-19F5-4117-9635-495729899F83Q47784419-5124CFCB-0941-42E9-92BD-B3D49B00B98AQ48109284-7F66B64E-744A-49DC-8F99-FA12EF968E08Q51737052-772EB692-BB35-4A34-B905-D54726D6F528Q52668513-1532127D-9395-43C2-B231-6FBF68140FEDQ54998956-F9B25399-9FAE-4352-B767-9DA64BE5FA9FQ58801187-752572D0-B052-4A93-8596-FA698142946A
P2860
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
SIMPLIFY-1: A Phase III Random ...... e Patients With Myelofibrosis.
@en
SIMPLIFY-1: A Phase III Random ...... e Patients With Myelofibrosis.
@nl
type
label
SIMPLIFY-1: A Phase III Random ...... e Patients With Myelofibrosis.
@en
SIMPLIFY-1: A Phase III Random ...... e Patients With Myelofibrosis.
@nl
prefLabel
SIMPLIFY-1: A Phase III Random ...... e Patients With Myelofibrosis.
@en
SIMPLIFY-1: A Phase III Random ...... e Patients With Myelofibrosis.
@nl
P2093
P356
P1476
SIMPLIFY-1: A Phase III Random ...... e Patients With Myelofibrosis.
@en
P2093
Andrzei Hellmann
Donal McLornan
Elliott F Winton
Francisco Cervantes
Jason Gotlib
John V Catalano
Julia D Maltzman
Kazuya Shimoda
Miklos Egyed
Ronald L Dubowy
P304
P356
10.1200/JCO.2017.73.4418
P407
P577
2017-09-20T00:00:00Z